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A Ab bs st tr ra ac ct t
The molecular diagnostics of genetically conditioned disorders is based on the identification of the mutations
in the predisposing genes. Hereditary cancer disorders of the gastrointestinal tracts are caused by mutations of
the tumour suppressor genes or the DNA repair genes. Occurrence of recurrent mutation allows improvement
of molecular diagnostics. The mutation spectrum in the genes causing hereditary forms of colorectal cancers
in the Polish population was previously described. In the present work an estimation of the frequency of the
recurrent mutations of the APC gene was performed. Eight types of mutations occurred in 19.4% of our FAP
families and these constitute 43% of all Polish diagnosed families. 
I In nt tr ro od du uc ct ti io on n
Molecular diagnostics of cancer predisposition is
very important for the medical treatment of the patient
and persons belonging to the high risk group.
Molecular studies enable the detection of mutation
carriers and release from unreasonable stress of
persons from the group with increased risk of cancer
occurrence. The mutation spectrums in the genes
predisposing to colorectal cancer in the Polish
population have been described [1-4]. In the present
work we focused on recurrent mutations of the APC
gene causing FAP [5].
Familial adenomatous polyposis (FAP) is
characterized by the appearance of numerous polyps
in the large intestine. Untreated polyps lead to the
development of colorectal cancer before age of 
50 years. FAP is a genetically determined disorder,
inherited in an autosomal dominant manner. The
correlation between mutations of the APC gene and
the occurrence of familial adenomatous polyposis was
described in 1991 [1, 2] and since then, mutations of
the APC gene have been investigated in research
centres leading to identification of various mutation
types. APC gene mutations arise de novo in 1 per
10,000 newborns. The APC gene is localized on
chromosome 5q21 and consists of 21 exons. Mutations
of the APC gene, in most cases, are small deletions or
insertions with the most frequent mutations, in the
greater part of the described populations, being the
AAAGA deletion at codon 1309 and the ACAAA
deletion at codon 1061.
P Pa at ti ie en nt ts s
Clinical diagnoses of FAP patients were conducted
in collaborating genetic centres or gastroenterology
clinics in the place of residence of patients. So far,
samples of DNA belonging to 280 Polish FAP families
have been collected in the DNA bank of Polish FAP
families established in 1997 at the Institute of Human
Genetics, Polish Academy of Science in Poznan.H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 196
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T Ta ab bl le e   1 1. .   Fifty-four recurrent mutations identified in APC gene and age of onset in a group of 124 diagnosed Polish FAP families
N No o. . F Fa am mi il ly y C Cl li in ni ic ca al l   m ma an ni if fe es st ta at ti io on n M Mu ut ta at ti io on n E Ex xo on n A Ag ge e   o of f   o on ns se et t
1. 9001 FAP 1490-1491insT 11 35
2. 9129 FAP 1490-1491insT 11 10
3. 9117 FAP 1500T>A 11 ND
4. 9141 FAP 1500T>A 11 ND
5. 9158 FAP 1500T>A 11 ND
6. 9182 FAP 1500T>A 11 ND
7. 9031 FAP 2626subC>T 15 ND
8. 9043 FAP 2626subC>T 15 30
9. 9099 FAP 2932C>T 15 ND
10. 9139 FAP 2932C>T 15 ND
11. 9152 FAP 2932C>T 15 ND
12. 9028 FAP 3183-3187delACAAA 15 28
13. 9067 FAP 3183-3187delACAAA 15 19
14. 9093 FAP 3183-3187delACAAA 15 17
15. 9108 FAP 3183-3187delACAAA 15 ND
16. 9111 FAP 3183-3187delACAAA 15 ND
17. 9192 FAP 3183-3187delACAAA 15 ND
18. 9262 FAP 3183-3187delACAAA 15 24
19. 9311 FAP 3183-3187delACAAA 15 ND
20. 9088 FAP 3202-3205delTCAA 15 30
21. 9106 FAP 3202-3205delTCAA 15 26
22. 9213 FAP 3202-3205delTCAA 15 28
23. 9226 FAP 3202-3205delTCAA 15 ND
24. 9342 FAP 3202-3205delTCAA 15 12
25. 9016 FAP 3927-3931delAAAGA 15 20
26. 9032 FAP 3927-3931delAAAGA 15 ND
27. 9036 FAP 3927-3931delAAAGA 15 13
28. 9059 FAP 3927-3931delAAAGA 15 18
M Mo ol le ec cu ul la ar r   m me et th ho od ds s
DNA was extracted from peripheral blood cells by
the classical phenol purification method and entire
coding sequence of APC gene was screened 
for mutations by PCR-HD and SSCP methods in 280
probands. DNA fragments showing heteroduplex or
additional pattern in SSCP analysis were sequenced
by direct PCR product sequencing and analyzed using
a MegaBace 500 sequencer according to the
manufacturer’s specifications.
R Re es su ul lt ts s   a an nd d   d di is sc cu us ss si io on n
We identified 72 mutations in 124 of our 280 FAP
families and observed eight types of recurrent mutations.
The mutations and age of onset are presented in 
Table 1. Two of them were localized in exon 11 and the
remaining six in the 3’ part of exon 15. The most 
frequent mutation, 3927-3931delAAAGA, occurred 
in twenty-eight families (10%); the second one was 
3183-3187delACAAA, occurring in eight families 
(2.8%); and the third most frequent mutation was 
3202-3205delTCAA, detected in 5 families (1.7%). 
In our FAP patients Y500X occurred in four families
(1.4%) while Q978X was detected in three families. Each
of the remaining four types of mutation occurred in two
families and the frequencies of these mutations were
below one percent.
In the Human Mutations Database at the Institute
of Medical Genetics in Cardiff 
(http://www.hgmd.cf.ac.uk/ac/gene.php?gene=APC),
considered the most representative population in the
world, seven hundred mutations are listed for the APCH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 197
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T Ta ab bl le e   1 1. .   Fifty-four recurrent mutations identified in APC gene and age of onset in a group of 124 diagnosed Polish FAP families
N No o. . F Fa am mi il ly y C Cl li in ni ic ca al l   m ma an ni if fe es st ta at ti io on n M Mu ut ta at ti io on n E Ex xo on n A Ag ge e   o of f   o on ns se et t
29. 9065 FAP 3927-3931delAAAGA 15 36
30. 9069 FAP 3927-3931delAAAGA 15 ND
31. 9071 FAP 3927-3931delAAAGA 15 36
32. 9075 FAP 3927-3931delAAAGA 15 ND
33. 9084 FAP 3927-3931delAAAGA 15 ND
34. 9103 FAP 3927-3931delAAAGA 15 26
35. 9104 FAP 3927-3931delAAAGA 15 ND
36. 9105 FAP 3927-3931delAAAGA 15 20
37. 9118 FAP 3927-3931delAAAGA 15 ND
38. 9142 FAP 3927-3931delAAAGA 15 ND
39. 9147 FAP 3927-3931delAAAGA 15 29
40. 9149 FAP 3927-3931delAAAGA 15 16
41. 9162 FAP 3927-3931delAAAGA 15 ND
42. 9187 FAP 3927-3931delAAAGA 15 ND
43. 9193 FAP 3927-3931delAAAGA 15 ND
44. 9229 FAP 3927-3931delAAAGA 15 22
45. 9235 FAP 3927-3931delAAAGA 15 ND
46. 9237 FAP 3927-3931delAAAGA 15 21
47. 9244 FAP  3927-3931delAAAGA 15 16
48. 9292 FAP  3927-3931delAAAGA 15 19
49. 9300 FAP  3927-3931delAAAGA 15 17
50. 9312 FAP 3927-3931delAAAGA 15 ND
51. 9321 FAP 3927-3931delAAAGA 15 31
52. 9324 FAP 3927-3931delAAAGA 15 ND
53. 9070 Gardner  syndrome 4129-4130delGT 15 ND
54. 9119 FAP 4129-4130delGT 15 ND
ND – no data available
gene. The most important mutation of the APC gene is
3927-3931delAAAGA. The frequency of these mutations
varies depending on populations. The mutation reports
describe the frequency of this mutation from 0% in
northwest Spain, 2.4% in the Australian population, 
5% in Dutch, 7% in Israeli to 16% in the group of Italian
FAP patients [6-9]. The second most frequent mutation,
3183-3187delACAAA, is reported with frequency
ranging from 0% in northwest Spain, 1.5% in Israeli
populations to 8.4% in Australia [6-9]. A study of over
100 Dutch families revealed equal frequency of those
two most frequent mutations (3927-3931delAAAGA 
and 3183-3187delACAAA) [10]. The largest studies 
of APC gene mutations were performed on a German
population [11, 12]. The latest published report in 2005
involved the analysis of over 1000 patients. In compa-
rison to this study, the representative study of mutation
frequency in the neighbouring population indicated two
times higher frequency of 3927-3931delAAAGA,
whereas a difference in frequency of 3183-3187del-
ACAAA was not observed (Germany 3.8%, Poland
2.7%). The frequency of 3202-3205delTCAA was equal
(1.7%) in both populations. In worldwide comparison
differences in the frequency of mutations were observed.
The Polish population of FAP patients belongs to 
the group where 3927-3931delAAAGA occurred with
higher frequency, whereas the frequency of mutation 
3183-3187del-ACAAA occurred with medium frequency
in comparison with other populations. The two recurrent
mutations localized on exon 11 were observed only in
the Polish population. In our two unrelated families with
1490-1491insT brain tumours were observed. Additio-
nally in one family desmoid tumours occurred [10, 13].
Another mutation (Q978X) did not occur with higherH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 198
frequency as described for other populations [14]. In our
FAP patient group Q283X, which occurs with frequency
of 4.5% in UK FAP patients, was not observed [13].
Recurrent mutations occurred in 54 Polish FAP families.
Screening for these mutations permitted us to diagnose
19% of all families in our population but eight types of
mutations constitute 43.5% of all our diagnosed families.
The mutation study in our population should involve these
eight mutations to improve molecular diagnostics of the
APC gene.
The study was financed by grant 2P05A10728 from
the Ministry of Science and Higher Education.
R Re ef fe er re en nc ce es s
1. Plawski A, Lubiñski J, Banasiewicz T, Paszkowski J, Lipinski D,
Strembalska A, Kurzawski G, Byrski T, Zajaczek S, Hodorowicz-
Zaniewska D, Gach T, Brozek I, Nowakowska D, Czkwaniec E,
Krokowicz P , Drews M, Zeyland J, Juzwa W, S³omski R. Novel
germline mutations in the adenomatous polyposis coli gene in
Polish families with familial adenomatous polyposis. J Med Genet
2004; 41: e11.
2. Skrzypczak M, Podralska M, Heinritz W, Froster UG, Lipinski D,
Slomski R, Plawski A. The MYH gene status in Polish FAP patients
without the APC gene mutations. Heredit Cancer Clin Pract
2006; 4: 43-47.
3. Kurzawski G, Suchy J, K³adny J, Safranow K, Jakubowska A, 
Elsakov P , Kucinskas V, Gardovski J, Irmejs A, Sibul H, Huzarski T,
Byrski T, Debniak T, Cybulski C, Gronwald J, Oszurek O, Clark J,
GóŸdŸ S, Niepsuj S, S³omski R, P³awski A, £acka-Wojciechowska A,
Rozmiarek A, Fiszer-Maliszewska £, Bebenek M, Sorokin D, 
Stawicka M, Godlewski D, Richter P , Brozek I, Wysocka B, Jawieñ A,
Banaszkiewicz Z, Kowalczyk J, Czudowska D, Goretzki PE, 
Moeslein G, Lubiñski J. Germline MSH2 and MLH1 mutational
spectrum in HNPCC families from Poland and the Baltic States. 
J Med Genet 2002; 39: E65.
4. Kurzawski G, Suchy J, Lener M, K³ujszo-Grabowska E, K³adny J,
Safranow K, Jakubowska K, Jakubowska A, Huzarski T, Byrski T,
Debniak T, Cybulski C, Gronwald J, Oszurek O, Oszutowska D,
Kowalska E, GóŸdŸ S, Niepsuj S, S³omski R, P³awski A, £acka-
Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska £, Bebenek M,
Sorokin D, Sasiadek MM, Stembalska A, Grzebieniak Z, Kilar E,
Stawicka M, Godlewski D, Richter P , Brozek I, Wysocka B, Limon J,
Jawieñ A, Banaszkiewicz Z, Janiszewska H, Kowalczyk J,
Czudowska D, Scott RJ, Lubiñski J. Germline MSH2 and MLH1
mutational spectrum including large rearrangements in HNPCC
families from Poland (update study). Clin Genet 2006; 69: 40-47.
5. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L,
Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al.
Identification and characterization of the familial adenomatous
polyposis coli gene. Cell 1991; 66: 589-600.
6. Gavert N, Yaron Y, Naiman T, Bercovich D, Rozen P , Shomrat R,
Legum C, Orr-Urtreger A. Molecular analysis of the APC gene in
71 Israeli families: 17 novel mutations. Hum Mutat 2002; 19: 664.
7. Schnitzler M, et al. Frequency of codon 1061 and codon 1309
APC mutations in Australian familial adenomatous polyposis
patients. Hum Mutat 1998; Suppl 1: S56-S57.
8. Ruiz-Ponte C, Vega A, Carracedo A, Barros F. Mutation analysis
of the adenomatous polyposis coli (APC) gene in northwest
Spanish patients with familial adenomatous polyposis (FAP) and
sporadic colorectal cancer. Hum Mutat 2001; 18: 355.
9. Varesco L, Gismondi V, James R, De Benedetti L, Heouaine A,
Biticchi R, Masetti E, Bertario L, Sala P , Grammatico P , et al. APC
gene mutations in Italian familial polyposis coli patients. Cancer
Detect Prev 1993; 17: 279-281.
10. van der Luijt RB, Khan PM, Vasen HF, Tops CM, van Leeuwen-
Cornelisse IS, Wijnen JT, van der Klift HM, Plug RJ, Griffioen G,
Fodde R. Molecular analysis of the APC gene in 105 Dutch
kindreds with familial adenomatous polyposis: 67 germline
mutations identified by DGGE, PTT, and southern analysis. Hum
Mutat 1997; 9: 7-16.
11. Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, 
Jungck M, Kadmon M, Wolf M, Fahnenstich J, Gebert J, Möslein
G, Mangold E, Propping P . Can APC mutation analysis contribute
to therapeutic decisions in familial adenomatous polyposis?
Experience from 680 FAP families. Gut 2001; 48: 515-521.
12. Friedl W, Aretz S. Familial adenomatous polyposis: experience
from a study of 1164 urelated German plyposis patients. Heredit
Cancer Clin Pract 2005; 3: 87-114.
13. Wallis Y, Morton D, McKeown C, Macdonald F. Molecular
analysis of the APC gene in 205 families: extended genotype-
phenotype correlations in FAP and evidence for the role of APC
amino acid changes in colorectal cancer predisposition. J Med
Genet 1999; 36: 14-20.
14. Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlström
J, Martinsson T, Nordling M, Hultcrantz R. Periampullary adenomas
and adenocarcinomas in familial adenomatous polyposis:
cumulative risks and APC gene mutations. Gastroenterology
2001; 121: 1127-1135.
Andrzej P³awski, Marta Podralska, Ryszard S³omski 